Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) France

Research

Date range: 1 April 2021 - 31 March 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)
Count Share
1 0.19

Outputs by subject (Share)

Outputs by subject
Subject Count Share
1 0.19

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 0.00

Compare Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) with other institutions

Collaboration

Date range: 1 April 2021 - 31 March 2022

International vs. domestic collaboration by Share

  • 100.00% Domestic
  • 0.00% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) by Share (11 total)

  1. Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and University of Bordeaux (0.82)
    Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)0.19
    University of Bordeaux0.64
  2. Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and National Institute for Health and Medical Research (INSERM) (0.39)
    Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)0.19
    National Institute for Health and Medical Research (INSERM)0.21
  3. Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and Laboratory of Excellence GR-Ex (0.37)
    Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)0.19
    Laboratory of Excellence GR-Ex0.19
  4. Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and Laboratory of Rare Diseases, Metabolism and Genetics (MRGM) (0.37)
    Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)0.19
    Laboratory of Rare Diseases, Metabolism and Genetics (MRGM)0.18
  5. Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and TBMCore (0.25)
    Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)0.19
    TBMCore0.06
  6. Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and French National Centre for Scientific Research (CNRS) (0.23)
    Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)0.19
    French National Centre for Scientific Research (CNRS)0.05
  7. Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and Sorbonne University (0.21)
    Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)0.19
    Sorbonne University0.03
  8. Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and University of Montpellier (0.21)
    Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)0.19
    University of Montpellier0.03
  9. Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and University of Paris (0.21)
    Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)0.19
    University of Paris0.03
  10. Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) and University of Paris-Sud (UPSud) (0.21)
    Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC)0.19
    University of Paris-Sud (UPSud)0.03

Top 10 international collaborators with Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) by Share (0 total)

Relationships

Partner Institutions

Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers (BMGIC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.